Masimo and Qualcomm join forces to develop advanced smartwatch platform for Wear OS
Masimo (NASDAQ: MASI), a global leader in medical technology, has announced a partnership with Qualcomm Technologies, Inc. to develop a next-generation smartwatch reference platform for ... Read More
MightySat Medical : Masimo introduces first FDA-cleared OTC medical fingertip pulse oximeter
Masimo (NASDAQ: MASI) has made an advancement in consumer health technology with the announcement of US Food and Drug Administration (FDA) clearance for MightySat Medical. ... Read More
Masimo W1 medical watch receives FDA 510(k) clearance for OTC and prescription use
Masimo (NASDAQ: MASI) has announced the FDA 510(k) clearance of the Masimo W1 medical watch for both over-the-counter (OTC) and prescription use. This groundbreaking approval ... Read More
Masimo gets FDA clearance for Centroid patient monitoring sensor
Masimo, a US medical device company, has received clearance from the US Food and Drug Administration (FDA) for Centroid, the company's wearable, wireless patient orientation, ... Read More